178 related articles for article (PubMed ID: 11766964)
1. Characterization of recombinant Bordetella pertussis adenylate cyclase toxins carrying passenger proteins.
Gmira S; Karimova G; Ladant D
Res Microbiol; 2001 Dec; 152(10):889-900. PubMed ID: 11766964
[TBL] [Abstract][Full Text] [Related]
2. Charge-dependent translocation of Bordetella pertussis adenylate cyclase toxin into eukaryotic cells: implication for the in vivo delivery of CD8(+) T cell epitopes into antigen-presenting cells.
Karimova G; Fayolle C; Gmira S; Ullmann A; Leclerc C; Ladant D
Proc Natl Acad Sci U S A; 1998 Oct; 95(21):12532-7. PubMed ID: 9770520
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the C-terminal domain essential for toxic activity of adenylate cyclase toxin.
Bejerano M; Nisan I; Ludwig A; Goebel W; Hanski E
Mol Microbiol; 1999 Jan; 31(1):381-92. PubMed ID: 9987138
[TBL] [Abstract][Full Text] [Related]
4. Bordatella pertussis adenylate cyclase: a toxin with multiple talents.
Ladant D; Ullmann A
Trends Microbiol; 1999 Apr; 7(4):172-6. PubMed ID: 10217833
[TBL] [Abstract][Full Text] [Related]
5. Delivery of CD8(+) T-cell epitopes into major histocompatibility complex class I antigen presentation pathway by Bordetella pertussis adenylate cyclase: delineation of cell invasive structures and permissive insertion sites.
Osicka R; Osicková A; Basar T; Guermonprez P; Rojas M; Leclerc C; Sebo P
Infect Immun; 2000 Jan; 68(1):247-56. PubMed ID: 10603395
[TBL] [Abstract][Full Text] [Related]
6. Induction of a polarized Th1 response by insertion of multiple copies of a viral T-cell epitope into adenylate cyclase of Bordetella pertussis.
Dadaglio G; Moukrim Z; Lo-Man R; Sheshko V; Sebo P; Leclerc C
Infect Immun; 2000 Jul; 68(7):3867-72. PubMed ID: 10858196
[TBL] [Abstract][Full Text] [Related]
7. Therapy of murine tumors with recombinant Bordetella pertussis adenylate cyclase carrying a cytotoxic T cell epitope.
Fayolle C; Ladant D; Karimova G; Ullmann A; Leclerc C
J Immunol; 1999 Apr; 162(7):4157-62. PubMed ID: 10201941
[TBL] [Abstract][Full Text] [Related]
8. Delivery of multiple epitopes by recombinant detoxified adenylate cyclase of Bordetella pertussis induces protective antiviral immunity.
Fayolle C; Osickova A; Osicka R; Henry T; Rojas MJ; Saron MF; Sebo P; Leclerc C
J Virol; 2001 Aug; 75(16):7330-8. PubMed ID: 11462005
[TBL] [Abstract][Full Text] [Related]
9. Structure-function studies of the adenylate cyclase toxin of Bordetella pertussis and the leukotoxin of Pasteurella haemolytica by heterologous C protein activation and construction of hybrid proteins.
Westrop G; Hormozi K; da Costa N; Parton R; Coote J
J Bacteriol; 1997 Feb; 179(3):871-9. PubMed ID: 9006045
[TBL] [Abstract][Full Text] [Related]
10. Direct delivery of the Bordetella pertussis adenylate cyclase toxin to the MHC class I antigen presentation pathway.
Guermonprez P; Ladant D; Karimova G; Ullmann A; Leclerc C
J Immunol; 1999 Feb; 162(4):1910-6. PubMed ID: 9973458
[TBL] [Abstract][Full Text] [Related]
11. Bioengineering of
Chenal A; Ladant D
Toxins (Basel); 2018 Jul; 10(7):. PubMed ID: 30037010
[TBL] [Abstract][Full Text] [Related]
12. Identification by in vitro complementation of regions required for cell-invasive activity of Bordetella pertussis adenylate cyclase toxin.
Iwaki M; Ullmann A; Sebo P
Mol Microbiol; 1995 Sep; 17(6):1015-24. PubMed ID: 8594322
[TBL] [Abstract][Full Text] [Related]
13. The adenylate cyclase toxin of Bordetella pertussis binds to target cells via the alpha(M)beta(2) integrin (CD11b/CD18).
Guermonprez P; Khelef N; Blouin E; Rieu P; Ricciardi-Castagnoli P; Guiso N; Ladant D; Leclerc C
J Exp Med; 2001 May; 193(9):1035-44. PubMed ID: 11342588
[TBL] [Abstract][Full Text] [Related]
14. Interaction of calcium with Bordetella pertussis adenylate cyclase toxin. Characterization of multiple calcium-binding sites and calcium-induced conformational changes.
Rose T; Sebo P; Bellalou J; Ladant D
J Biol Chem; 1995 Nov; 270(44):26370-6. PubMed ID: 7592850
[TBL] [Abstract][Full Text] [Related]
15. Translocation and calmodulin-activation of the adenylate cyclase toxin (CyaA) of Bordetella pertussis.
Voegele A; O'Brien DP; Subrini O; Sapay N; Cannella SE; Enguéné VYN; Hessel A; Karst J; Hourdel V; Perez ACS; Davi M; Veneziano R; Chopineau J; Vachette P; Durand D; Brier S; Ladant D; Chenal A
Pathog Dis; 2018 Nov; 76(8):. PubMed ID: 30452651
[TBL] [Abstract][Full Text] [Related]
16. Recombinant adenylate cyclase toxin of Bordetella pertussis induces cytotoxic T lymphocyte responses against HLA*0201-restricted melanoma epitopes.
Dadaglio G; Morel S; Bauche C; Moukrim Z; Lemonnier FA; Van Den Eynde BJ; Ladant D; Leclerc C
Int Immunol; 2003 Dec; 15(12):1423-30. PubMed ID: 14645151
[TBL] [Abstract][Full Text] [Related]
17. The Eukaryotic Host Factor 14-3-3 Inactivates Adenylate Cyclase Toxins of Bordetella bronchiseptica and B. parapertussis, but Not B. pertussis.
Fukui-Miyazaki A; Toshima H; Hiramatsu Y; Okada K; Nakamura K; Ishigaki K; Shinzawa N; Abe H; Horiguchi Y
mBio; 2018 Aug; 9(4):. PubMed ID: 30154257
[No Abstract] [Full Text] [Related]
18. Bordetella pertussis adenylate cyclase toxin: a vehicle to deliver CD8-positive T-cell epitopes into antigen-presenting cells.
Guermonprez P; Fayolle C; Karimova G; Ullmann A; Leclerc C; Ladant D
Methods Enzymol; 2000; 326():527-42. PubMed ID: 11036662
[No Abstract] [Full Text] [Related]
19. Targeted mutations that ablate either the adenylate cyclase or hemolysin function of the bifunctional cyaA toxin of Bordetella pertussis abolish virulence.
Gross MK; Au DC; Smith AL; Storm DR
Proc Natl Acad Sci U S A; 1992 Jun; 89(11):4898-902. PubMed ID: 1594590
[TBL] [Abstract][Full Text] [Related]
20. Chemical fatty acylation confers hemolytic and toxic activities to adenylate cyclase protoxin of Bordetella pertussis.
Heveker N; Bonnaffé D; Ullmann A
J Biol Chem; 1994 Dec; 269(52):32844-7. PubMed ID: 7806509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
